The role of neuroimaging in neurocutaneous disorders is an evolving field. Research can be inconsistent and inconclusive, leading to divergent practice for some disorders. This study provides an overview of …
Hydroxyurea: a reappraisal of its cutaneous side effects and their management.
Hydroxyurea (HU) is known to cause a broad spectrum of cutaneous side effects, ranging from relatively benign to severe. Although dermatologists are often consulted for the treatment of these side …
Systematic review to identify and appraise patient-reported outcome measures on treatment satisfaction in acne.
After dermatitis, acne is the second skin disease most contributing to the burden of skin diseases worldwide. Recently, seven core outcome domains have been identified that together form an Acne …
Comorbidities of alopecia areata – a population-based cohort study.
Previous studies have associated AA with a number of comorbidities. However, the timing between AA and development of such comorbidities remains poorly understood.To examine the temporal relationship between AA diagnosis …
The clinico-epidemiological characteristics and therapeutic experience of 152 patients with cutaneous sporotrichosis: a 10-year retrospective study from India.
Cutaneous sporotrichosis, a subcutaneous mycosis because of Sporothrix schenckii, is sporadic worldwide with local hyperendemic pockets.To study clinico-epidemiological and therapeutic aspects of sporotrichosis in our clinic.We retrospectively analyzed medical records …
Mimics of melanoma in reflectance confocal microscopy.
The diagnosis of melanoma is challenging for both dermatologists and oncologists. Incidence of melanoma increases at a rate of 3-7% per year. Usage of modern tools such as dermoscopy and …
Hydroquinone: myths and reality.
Hydroquinone has pharmacological uses in disorders of pigmentation because of its ability to competitively inhibit the enzyme tyrosinase. Our contemporary review presents the strongest evidence supporting the use of hydroquinone …
Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic AhR modulating agent (TAMA).
Tapinarof, a novel, first-in-class small-molecule topical therapeutic aryl hydrocarbon receptor (AhR) modulating agent (TAMA), is in clinical development for the treatment of psoriasis and atopic dermatitis. The efficacy of tapinarof …
The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Mycosis fungoides (MF) and Sézary syndrome (SS) are the best studied subtypes of cutaneous T-cell lymphoma, and the level of blood tumour burden in patients is important for diagnosis, disease …
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020.
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of cutaneous squamous cell carcinoma (cSCC). The document aims to: offer an appraisal of all …